Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.

Kurotsu S, Tanaka K, Niino T, Asano T, Sugizaki T, Azuma A, Suzuki H, Mizushima T.

J Pharmacol Exp Ther. 2014 Jul;350(1):79-88. doi: 10.1124/jpet.114.213009. Epub 2014 Apr 25.

2.

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.

Int Immunopharmacol. 2014 Oct;22(2):498-504. doi: 10.1016/j.intimp.2014.07.010. Epub 2014 Aug 10.

PMID:
25111852
3.

Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.

Tanaka KI, Azuma A, Miyazaki Y, Sato K, Mizushima T.

Chest. 2012 Oct;142(4):1011-1019. doi: 10.1378/chest.11-2879.

PMID:
22459774
4.

Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis.

Nagao S, Taguchi K, Sakai H, Tanaka R, Horinouchi H, Watanabe H, Kobayashi K, Otagiri M, Maruyama T.

Biomaterials. 2014 Aug;35(24):6553-62. doi: 10.1016/j.biomaterials.2014.04.049. Epub 2014 May 6.

PMID:
24811261
5.

Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.

Tanaka K, Ishihara T, Sugizaki T, Kobayashi D, Yamashita Y, Tahara K, Yamakawa N, Iijima K, Mogushi K, Tanaka H, Sato K, Suzuki H, Mizushima T.

Nat Commun. 2013;4:2686. doi: 10.1038/ncomms3686.

PMID:
24189798
6.

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Zhu Y, Liu Y, Zhou W, Xiang R, Jiang L, Huang K, Xiao Y, Guo Z, Gao J.

Respir Res. 2010 Mar 20;11:34. doi: 10.1186/1465-9921-11-34.

7.

Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice.

Hirata H, Arima M, Fukushima Y, Sugiyama K, Tokuhisa T, Fukuda T.

Respirology. 2013 May;18(4):674-81. doi: 10.1111/resp.12072.

PMID:
23432979
8.

[Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].

Wang SJ, Bai W, Wang CL, Dai Z.

Zhongguo Zhong Yao Za Zhi. 2007 Dec;32(24):2623-7. Chinese.

PMID:
18338602
9.

Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.

Tanaka R, Watanabe H, Kodama A, Chuang VT, Ishima Y, Hamasaki K, Tanaka K, Mizushima T, Otagiri M, Maruyama T.

J Pharmacol Exp Ther. 2013 May;345(2):271-83. doi: 10.1124/jpet.112.201814. Epub 2013 Feb 26.

10.
11.

VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.

Ou XM, Li WC, Liu DS, Li YP, Wen FQ, Feng YL, Zhang SF, Huang XY, Wang T, Wang K, Wang X, Chen L.

Int Immunopharmacol. 2009 Jan;9(1):70-9. doi: 10.1016/j.intimp.2008.10.002. Epub 2008 Oct 29.

PMID:
18976720
12.

Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.

Kim JW, Rhee CK, Kim TJ, Kim YH, Lee SH, Yoon HK, Kim SC, Lee SY, Kwon SS, Kim KH, Kim YK.

Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1055-63. doi: 10.1111/j.1440-1681.2010.05431.x.

PMID:
20659133
13.

Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Shimbori C, Shiota N, Okunishi H.

Eur J Pharmacol. 2011 Jan 10;650(1):424-30. doi: 10.1016/j.ejphar.2010.09.084. Epub 2010 Oct 27.

PMID:
21034736
14.

Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.

Liu W, Wan J, Han JZ, Li C, Feng DD, Yue SJ, Huang YH, Chen Y, Cheng QM, Li Y, Luo ZQ.

Respir Res. 2013 Oct 8;14:101. doi: 10.1186/1465-9921-14-101.

15.

Inhibitory effect of safflor yellow on pulmonary fibrosis.

Wang L, Jin M, Zang BX, Wu Y.

Biol Pharm Bull. 2011;34(4):511-6.

16.

Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.

Langenbach SY, Wheaton BJ, Fernandes DJ, Jones C, Sutherland TE, Wraith BC, Harris T, Schuliga MJ, McLean C, Stewart AG.

Can J Physiol Pharmacol. 2007 Jul;85(7):727-38.

PMID:
17823636
17.
18.

[Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].

Hu P, Gao ZC.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Aug;18(8):474-8. Chinese.

19.

Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.

Wang X, Ouyang Z, You Q, He S, Meng Q, Hu C, Wu X, Shen Y, Sun Y, Wu X, Xu Q.

Toxicol Appl Pharmacol. 2016 Jul 15;303:21-29. doi: 10.1016/j.taap.2016.05.005. Epub 2016 May 11.

PMID:
27180239
20.

Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.

Zhao L, Wang X, Chang Q, Xu J, Huang Y, Guo Q, Zhang S, Wang W, Chen X, Wang J.

Eur J Pharmacol. 2010 Feb 10;627(1-3):304-12. doi: 10.1016/j.ejphar.2009.11.007. Epub 2009 Nov 10.

PMID:
19909737

Supplemental Content

Support Center